Bard Pharmaceuticals Ltd

128 results for Bard Pharmaceuticals Ltd

  • vLex Rating
  • More Adventures In Personal Jurisdiction − Examining The BMS “Federal Court” Caveat

    We’ll be hitting all the Presidents’ Day sales today, but something tells me we’ll be disappointed because we won’t be able to buy, beg, borrow, or steal a new one.  So we keep trying. With plaintiffs desperate to find some way to continue pursuing aggravated, aggregated product liability litigation in their favorite venues after Daimler AG...

    ...AstraZeneca Pharmaceuticals, LP, 634 F.3d 1352, 1364 (11th Cir. 2011); Upper Deck Co., LLC v. Federal ...Supp.3d 1040, 1048-49 (N.D. Ill. 2016); In re: Bard IVC, 2016 WL 6393596, at *4 n.4 (D. Ariz. Oct. 28, 2016); In re: Zofran ...

  • Procrastination, deadlines, and statutes of limitation.

    ... email to communicate, automobiles and airplanes to travel, pharmaceuticals to treat disease, and so on. None of these inventions pre-dated 1850, much ...[section] 302(a) (2000). . (242.) See, e.g., Robert L. Bard & Lewis Kurlantzick, Copyright Duration at the Millennium, 47 J. COPYRIGHT ...

  • The disintegration of intellectual property? A classical liberal response to a premature obituary.

    ... What Price to Innovation: Does the Compulsory Licensing of Pharmaceuticals Hurt Innovation?, 18 BERKELEY TECH. L.J. 853 (2003) (reporting that ...Dist. No. 2 v. Hyde, 466 U.S. 2 (1984). . (180.) C.R. Bard, Inc. v. M3 Sys., Inc., 157 F.3d 1340, 1372 (Fed. Cir. 1998). . (181.) See ...

  • Federal Circuit Patent Updates - January/February 2015

    ... Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc. (No. 13-854, 1/20/15). January 20, 2015 1:09 ... A full version of the text is available in PDF form. Bard Peripheral Vascular v. W.L. Gore & Associates (No. 2014-1114, 1/13/15) ...

  • Preemption and Second-Guessing FDA Classifications

    The “fraud on the FDA” claim that the Supreme Court held preempted in Buckman Co. v. Plaintiffs Legal Committee, 531 U.S. 341 (2001), was actually the most extreme form of a private plaintiff second-guessing the result of an FDA process classifying a regulated product.  Plaintiffs claimed that, because of purported “fraud” in the §510(k) process,...

    ... interpret and enforce its own regulations.”  Sandoz Pharmaceuticals Corp. v. Richardson-Vicks, Inc., 902 F.2d 222, 231 (3d Cir. 1990).  See ...C.R. Bard, Inc., 413 F. Supp.3d 770, 784 (N.D. Ill. 2019), filed a complaint ...

  • Current decisions.

    ...Merrell Dow Pharmaceuticals Inc., 509 U.S. 579 (1993). The trial court would have to determine whether ...Bard Inc., and the distributor, Baxter Healthcare Corp., the court's majority ...

  • A Guide To Medication Guides

    Not too long ago we were asked what we thought about warning claims involving medication guides.   Our off-the-cuff reaction was that such suits have been occasionally filed over the years, but were largely unsuccessful in achieving the plaintiffs’ primary goal, which almost always was to avoid the learned intermediary rule. That was our gut reaction, but since we also have to...

    ...Supp.2d at 1290.  See Ellis v. C.R. Bard, Inc., 311 F.3d 1272, 1280-81 (11th Cir. 2002) (learned intermediary rule ...Bayer Healthcare Pharmaceuticals, Inc., 2013 WL 1289050, at *6 n.3 (W.D. La. March 26, 2013). The contents ...

  • Prescription Medical Product Causation – Expert Required – Part One

    ... complex causation issues, including cases involving pharmaceuticals or medical devices, to establish causation, plaintiffs must offer ...C. R. Bard, Inc., 2017 WL 2350228, at *3 (S.D.W. Va. May 30, 2017) (with expert ...

  • Information to help you use this book.

    ... include: American Express, Firemans Fund, UC Press, Syntex Pharmaceuticals & Oakland A's. 35 mm., 120 & 4 x 5" formats. Call or Fax for mail out ...CLARK, Ruth Ann COMM. SPEC. (18) USCI BARD 1200 Technology Park Billerica, MA 01821 USA (508) 670-4323 Fax: (508) ...

  • IP Update, Vol. 15, No. 2, February 2012

    In This Issue: Patents USPTO Releases Proposed Rules and Fees for Post-Grant Procedures Patentee’s Expert’s Testimony Regarding 40-Year-Old Reference Does Not Overcome the Reference Disclosure ANDA Allegation May Confer Subject-Matter Jurisdiction, But Not State a Claim upon which Relief Can...

  • Breaking News – Bauman Trumps Jurisdiction By Consent in Second Circuit – and New Post-Bauman Cheat Sheet on General Personal Jurisdiction

    It has been a little over two years since the Supreme Court issued its decision in Bauman v. AG Daimler, and, from our perspective, its impact has been significant, even earth shaking (no pun intended, and we have a San Francisco office and certainly would not make light of earthquakes). We previously discussed Bauman’s impact on...

    ... AstraZeneca AB v. Mylan Pharmaceuticals, Inc. , 72 F. Supp.3d 549 (D. Del. Nov. 5, 2014), certified for ...Third-party contribution claim. In re Bard IVC Filters Products Liability Litigation , 2016 WL 6393595 (D. Ariz. Oct. ...

  • Best Ways to Use Patent Venue Discovery After TC Heartland

    Nearly three years after the U.S. Supreme Court’s decision in TC Heartland LLC v. Kraft Food Brands LLC,1 both parties and courts continue to grapple with what it means for a defendant to have a regular and established place of business in a judicial district that is not where a named domestic defendant in a patent infringement case is either incorporated or resides. Originally...

    ...23 . As another example, in C.R. Bard Inc. v. Angiodynamics Inc ., the U.S. District Court for the District of ...34 . In Novartis Pharmaceuticals Corp. v. Accord Healthcare Inc ., 35 for instance, the Delaware district ...

  • Too Bad Its Unpublished

    A reader recently recommended that we take a look at Rounds v. Genzyme Corp., ___ Fed. Appx. ___, 2011 WL 3925353, slip op. (11th Cir. Sept. 8, 2011) (applying Florida law), even though it’s unpublished.  We’d blogged about this case when the district court first dismissed it, but we confess we’ve missed the affirmance because...

    ...C.R. Bard, Inc., 311 F.3d 1272, 1283 (11th Cir. 2002) (applying Georgia law).  ...Novartis Pharmaceuticals Corp., 283 F.3d 254, 268 (5th Cir. 2002) (no need for separate warnings ...

  • Prescription Medical Product Causation – Expert Required

    We recently blogged about the final chapter (at the district court level, anyway) of the big defense win in the Mirena MDL.  The long-overdue result was entry of summary judgment for the defendant against all claims.  As the blog also chronicled, the key Mirena decision had been earlier – and was already appealed and affirmed...

    ... complex causation issues, including cases involving pharmaceuticals or medical devices, to establish causation, plaintiffs must offer ...C. R. Bard, Inc. , 2017 WL 2350228, at *3 (S.D.W. Va. May 30, 2017) (with expert ...

  • Spencer Stuart/Directors & Boards Directors Roster.

    .... AMYLIN PHARMACEUTICALS INC. . San Diego, CA . has added to its board: . Thomas R. Testman . Bio .... Woodbury, NY . has added to its board: . John F. Bard . Bio Notes: Retired in 2000 as EVP of Win. Wrigley Jr. Co., which he ...

  • Unraveling the patent-antitrust paradox.

    ... in which patents are critical to innovation, such as pharmaceuticals. And it anticipates a more significant role for the antitrust laws in ...Bard, Inc. v. M3 Systems, Inc., 157 F.3d 1340 (Fed. Cir. 1998). In this case, ...

  • Too Bad Its Unpublished

    A reader recently recommended that we take a look at Rounds v. Genzyme Corp., ___ Fed. Appx. ___, 2011 WL 3925353, slip op. (11th Cir. Sept. 8, 2011) (applying Florida law), even though it’s unpublished. We’d blogged about this case when the district court first dismissed it, but we confess we’ve missed the affirmance because our online check of Eleventh Circuit opinions only brings up opinions...

  • Product Liability Update: July 2018

    Massachusetts Federal Court Holds No Personal Jurisdiction Over Foreign Manufacturer Which, Although It Used A Nationwide United States Distributor, Did Not Specifically Target Massachusetts For Sales - In Preferred Mut. Ins. Co. v. Stadler Form Aktiengesellschaft, 2018 U.S. Dist. LEXIS 55475 (Mar. 30, 2018), a homeowners’ insurer as subrogee sued the retailer, U.S. distributor and...

  • Reclaiming humanity: economic, social, and cultural rights as the cornerstone of African human rights.

    ...) Bess-Carolina Dolmo, Examining Global Access to Essential Pharmaceuticals in the Face of Patent Protection Rights: The South African Example, 7 ...See supra note 46. . (146.) See Bard-Anders Andreassen, Article 22, in THE UNIVERSAL DECLARATION OF HUMAN ...

  • Don’t Forget About A Prescribing Physician’s Failure To Read Warnings

    For some reason, we recently found ourselves comparing our favorite defenses to our favorite rock bands.  Preemption, of course, would be The Beatles, and Daubert/Frye the Rolling Stones.  The learned intermediary rule could be Bob Dylan (I know, we’re showing our age, here).  Comment k could correspond to Led Zeppelin, and state of the art...

    ... at 380.  See Carter v. APP Pharmaceuticals, LLC , 2013 WL 5532767, at *8 (D. Ariz. Aug. 13, 2013) (plaintiff’s ... Id. at 844. Likewise, In re C.R. Bard, Inc., Pelvic Repair System Products Liability Litigation , 2013 WL ...

  • Antitrust by Analogy: Developing Rules for Loyalty Rebates and Bundled Discounts

    Economics has come to dominate antitrust jurisprudence. Preserving and enhancing economic welfare (in one form or another) is now the conceded goal of antitrust. Accordingly, economic analysis permeates antitrust scholarship, drives agency decisions, and is the basis of modern judicial decisions. The thought of developing an antitrust liability rule without a well-considered underlying economic...

  • Advertising agency survey.

    ...1969/42 $3 mil. * Wayne Home Equipment * Bekins Van Lines * Bard Manufacturing * Central Soya * Peg Perego U.S.A. . Marquart Corp. Design & ... NTS Apartment Communities * Charmilles Technologies * Quad Pharmaceuticals . DJ Floyd & Partners Inc. * 317/848-8884 David Floyd, Pres. 1985/5 DND ...

  • Antitrust violations.

    ...See C.R. Bard, Inc. v. M3 Systems, Inc., 157 F.3d 1340, 1368 (Fed Cir. 1998) (holding ...25, 1998) (discussing roles and penalties of Fujisawa Pharmaceuticals Ltd. and the Dutch Companies of Azko Nobel Chemical BV and Glucona BV in ...

  • Antitrust violations.

    ...C.R. Bard, Inc. v. M3 Systems, Inc., 157 F.3d 1340, 1368 (Fed Cir. 1998) (holding ...25, 1998) (discussing roles and penalties of Fujisawa Pharmaceuticals Ltd. and the Dutch Companies of Azko Nobel Chemical BV and Glucona BV in ...

  • Patents Comparative Guide

    ... For pharmaceuticals and medical devices, US law (35 USC § 156) provides for a patent term ... reasons, the patentee may be subjected to antitrust liability (CR Bard, Inc v M3 Sys, Inc, 157 F.3d 1340 (Fed Cir 1998)). Joining patent pools ...